A Multicentre, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of Retigabine Immediate-release (IR) in Asian Adults With Partial Onset Seizures (Extension of Study RTG114855)
收藏DataCite Commons2026-03-18 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00005284/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This is a multicentre, long-term, open-label extension (OLE) study to assess the long-term safety, tolerability and efficacy of retigabine immediate-release (IR) as adjunctive therapy in adult Asian subjects with drug-resistant partial-onset seizures (POS).
提供机构：
Vivli
创建时间：
2020-02-13
